Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: achieve

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Neftaly Vutisani Malatjie

in

  • Neftaly To increase the number of PLHIV and key and vulnerable populations who are aware of their status, are linked to and retained in care on ART, and achieve and maintain viral suppression

    Neftaly To increase the number of PLHIV and key and vulnerable populations who are aware of their status, are linked to and retained in care on ART, and achieve and maintain viral suppression

  • Neftaly By end of 2027, promote and maintain a culture of evidence-based decision making to achieve malaria program performance at all levels

    Neftaly By end of 2027, promote and maintain a culture of evidence-based decision making to achieve malaria program performance at all levels

  • Neftaly By the end of 2027, strengthen and maintain capacity for program management, coordination and partnership to achieve malaria program performance at all levels

    Neftaly By the end of 2027, strengthen and maintain capacity for program management, coordination and partnership to achieve malaria program performance at all levels

  • Neftaly To achieve at least 90% of people with TB provided with universal drug susceptibility testing by 2026

    Neftaly To achieve at least 90% of people with TB provided with universal drug susceptibility testing by 2026

  • Neftaly To achieve a treatment success rate of at least 91% for all form of TB by 2026

    Neftaly To achieve a treatment success rate of at least 91% for all form of TB by 2026

  • Neftaly To achieve a treatment success rate of at least 80% for RR/MDR-TB by 2026

    Neftaly To achieve a treatment success rate of at least 80% for RR/MDR-TB by 2026

  • Neftaly To achieve ART coverage of at least 63% of PLHIV by 2026

    Neftaly To achieve ART coverage of at least 63% of PLHIV by 2026

  • Neftaly To achieve 100% parasitological diagnosis of fever/suspected cases and 100% effective treatment of all confirmed cases according to the national guidelines at health facilities by 2017

    Neftaly To achieve 100% parasitological diagnosis of fever/suspected cases and 100% effective treatment of all confirmed cases according to the national guidelines at health facilities by 2017

    Neftaly Goal: Achieving 100% Parasitological Diagnosis and Effective Treatment of Malaria by 2017

    Accurate diagnosis and prompt, effective treatment are essential pillars in the fight against malaria. Neftaly is committed to supporting Namibia’s Ministry of Health and Social Services in achieving:

    100% parasitological diagnosis of all fever or suspected malaria cases at health facilities, and
    100% effective treatment of all confirmed malaria cases in accordance with national treatment guidelines by 2017.

    Strategic Focus Areas

    1. Universal Access to Quality Diagnostic Services

    • Scale up availability of malaria rapid diagnostic tests (RDTs) and microscopy in all public health facilities
    • Train health workers in proper use of diagnostic tools and interpretation of results
    • Ensure functional laboratory equipment and reliable supply chains for diagnostic commodities
    • Promote adherence to test-before-treat protocols to reduce presumptive treatment and improve case management accuracy

    2. Ensuring 100% Effective Treatment

    • Guarantee uninterrupted supply of first-line artemisinin-based combination therapies (ACTs) and other approved antimalarial drugs
    • Train healthcare providers on national malaria treatment guidelines, including management of severe and complicated malaria
    • Implement monitoring systems to track treatment adherence, patient outcomes, and drug resistance trends
    • Provide patient education on completing treatment regimens and recognizing danger signs

    3. Quality Assurance and Supervision

    • Conduct regular supportive supervision and mentorship to ensure compliance with diagnostic and treatment standards
    • Establish quality control mechanisms for laboratory diagnostics and treatment delivery
    • Use routine data to identify gaps and promptly address challenges in diagnosis and case management

    4. Community Awareness and Demand Creation

    • Educate communities on the importance of seeking testing for all fevers and completing prescribed treatments
    • Engage community health workers in reinforcing messages about malaria diagnosis and treatment adherence
    • Address misconceptions around testing and treatment to improve acceptance and trust

    Expected Outcomes by 2017

    • Every person presenting with fever or suspected malaria at a health facility receives a parasitological test to confirm or rule out malaria
    • All confirmed malaria cases receive effective treatment consistent with the latest national guidelines
    • Reduction in unnecessary antimalarial drug use, lowering the risk of drug resistance development
    • Improved malaria case management contributing to reduced transmission, morbidity, and mortality
  • Neftaly To achieve 95% of targeted population protected with at least one appropriate vector control intervention by 2017

    Neftaly To achieve 95% of targeted population protected with at least one appropriate vector control intervention by 2017

    Neftaly Goal: Protecting 95% of the Targeted Population with Effective Vector Control Interventions by 2017

    Vector control remains a cornerstone in the fight against malaria, directly reducing transmission by targeting the mosquitoes that spread the disease. Neftaly is dedicated to supporting Namibia’s malaria elimination efforts by ensuring:

    At least 95% of the targeted population is protected with at least one appropriate vector control intervention by 2017.

    Key Vector Control Interventions

    1. Long-Lasting Insecticidal Nets (LLINs)

    • Wide-scale distribution of LLINs to vulnerable groups, including children under five and pregnant women
    • Regular community campaigns to replace worn-out nets and promote consistent, correct usage
    • Community education to increase net care and usage rates

    2. Indoor Residual Spraying (IRS)

    • Annual IRS campaigns conducted with high coverage in malaria-endemic areas
    • Training and equipping spray teams to ensure effective application and safety
    • Monitoring insecticide resistance and adapting strategies accordingly

    3. Environmental Management and Larval Source Control

    • Community mobilization for environmental cleanup to reduce mosquito breeding sites
    • Promotion of drainage, water management, and other habitat reduction techniques where applicable

    Strategies for Achieving High Coverage

    • Collaborate with regional and district health authorities to plan and implement vector control campaigns
    • Engage community leaders and health workers to build trust and acceptance of interventions
    • Use data-driven targeting to prioritize high-risk populations and geographic hotspots
    • Strengthen supply chains to ensure uninterrupted availability of vector control commodities
    • Monitor coverage and effectiveness through household surveys and entomological surveillance

    Expected Impact

    Achieving 95% coverage with vector control interventions will:

    • Substantially reduce malaria transmission and incidence
    • Protect vulnerable populations, lowering morbidity and mortality rates
    • Support Namibia’s progress toward malaria elimination and sustainable control
    • Contribute to healthier communities and stronger health systems
  • Neftaly To achieve 90% viral suppression among PLHIVs on ART by 2021.

    Neftaly To achieve 90% viral suppression among PLHIVs on ART by 2021.

    Neftaly: Achieving 90% Viral Suppression Among PLHIV on ART

    Overview

    Viral suppression is a critical indicator of the success of antiretroviral therapy (ART) and a cornerstone of efforts to control the HIV epidemic. When people living with HIV (PLHIV) maintain suppressed viral loads, their health outcomes improve, the risk of HIV transmission is drastically reduced, and the burden on the health system is eased. Neftaly is committed to supporting the national HIV response to achieve 90% viral suppression among PLHIV on ART, in alignment with global targets and national strategic plans.

    Goal

    To ensure that 90% of people living with HIV receiving ART achieve and maintain viral suppression, through improved adherence support, service quality, monitoring, and community engagement.

    Strategic Objectives

    1. Improve Access to High-Quality ART Services

    • Ensure a consistent supply of optimal antiretroviral regimens, including first-line and second-line options.
    • Decentralize ART services and expand differentiated service delivery (DSD) models to make treatment more accessible and patient-centered.
    • Strengthen clinical management of HIV to address co-morbidities and treatment failure.

    2. Strengthen Adherence Support and Retention in Care

    • Implement adherence counselling, peer support, and community-based follow-up to improve long-term ART retention.
    • Use digital tools (SMS reminders, mobile apps) to support adherence and track missed appointments.
    • Engage family members and community networks to support treatment continuity and stigma reduction.

    3. Expand Access to Viral Load Testing

    • Scale up routine viral load testing and monitoring in line with national guidelines.
    • Ensure timely sample transport, laboratory capacity, and result turnaround to inform clinical decision-making.
    • Use viral load data to identify and respond to cases of virologic failure promptly.

    4. Train and Equip Health Providers

    • Build the capacity of healthcare workers in ART management, patient communication, and viral load interpretation.
    • Promote task-shifting and mentorship programs to optimize the use of available human resources.
    • Implement quality improvement initiatives to ensure consistent, high-standard HIV care.

    5. Strengthen Monitoring and Evaluation

    • Use national health information systems to track viral suppression rates and identify gaps across regions and populations.
    • Conduct regular cohort analyses to evaluate treatment outcomes and program effectiveness.
    • Report progress toward the 90% viral suppression target to guide policy and resource allocation.

    Expected Outcomes

    • At least 90% of PLHIV on ART achieve viral suppression by the target year.
    • Improved health outcomes and quality of life for people living with HIV.
    • Reduced HIV transmission at community level (“Undetectable = Untransmittable” or U=U).
    • Stronger and more responsive ART service delivery system.
    • Increased public confidence and engagement in the national HIV response.

    Conclusion

    Achieving 90% viral suppression among PLHIV on ART is a pivotal step toward ending AIDS as a public health threat. Neftaly is dedicated to supporting health systems, communities, and individuals to meet this target through strategic investment, innovation, and collaboration—ensuring that every person on treatment can live a long, healthy life with dignity.